Sergio Ruiz‐Llorente
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 7
-
- Thyroid Cancer Diagnosis and Treatment 4
-
- Protein Degradation and Inhibitors 3
- RNA modifications and cancer 3
-
- Cancer Immunotherapy and Biomarkers 4
-
- Adrenal and Paraganglionic Tumors 5
- Bladder and Urothelial Cancer Treatments 4
- Urinary and Genital Oncology Studies 4
- Co-authors
- Mercedes RobledoJavier Benı́tezArancha CebriánVerónica García-CarpizoJacinto SarmenteroMaría J. BarreroDavid G. PisanoAlberto Cascón
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nucleic Acids Research (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Sergio Ruiz‐Llorente
28 papers receiving 662 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 202
- Endocrinology, Diabetes and Metabolism 215
- Molecular Biology 353
- Oncology 116
- Genetics 104
Countries citing papers authored by Sergio Ruiz‐Llorente
This map shows the geographic impact of Sergio Ruiz‐Llorente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Ruiz‐Llorente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Ruiz‐Llorente more than expected).
Fields of papers citing papers by Sergio Ruiz‐Llorente
This network shows the impact of papers produced by Sergio Ruiz‐Llorente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Ruiz‐Llorente. The network helps show where Sergio Ruiz‐Llorente may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sergio Ruiz‐Llorente, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 15 | |
| 3 | 2024 | 0 | |
| 4 | 2022 | 15 | |
| 5 | 2022 | 8 | |
| 6 | 2021 | 5 | |
| 7 | 2019 | 28 | |
| 8 | 2018 | 44 | |
| 9 | 2016 | 42 | |
| 10 | 2013 | 7 | |
| 11 | 2013 | 2 | |
| 12 | 2012 | 12 | |
| 13 | 2012 | 36 | |
| 14 | 2007 | 30 | |
| 15 | 2005 | 44 | |
| 16 | 2004 | 24 | |
| 17 | 2004 | 79 | |
| 18 | 2004 | 25 | |
| 19 | 2003 | 14 | |
| 20 | 2002 | 46 |
About Sergio Ruiz‐Llorente
Sergio Ruiz‐Llorente is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism and Surgery, having authored 30 papers that have together received 680 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (7 papers), Adrenal and Paraganglionic Tumors (5 papers), Bladder and Urothelial Cancer Treatments (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Urinary and Genital Oncology Studies (4 papers), Thyroid Cancer Diagnosis and Treatment (4 papers), Protein Degradation and Inhibitors (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (202 citations), Endocrinology, Diabetes and Metabolism (215 citations) and Molecular Biology (353 citations). Sergio Ruiz‐Llorente has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Mercedes Robledo, Javier Benı́tez, Arancha Cebrián, Verónica García-Carpizo, Jacinto Sarmentero, María J. Barrero, David G. Pisano, Alberto Cascón, Marina Pollán and Cristina Montero‐Conde. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.